Medicines Evaluation Unit
Established in 1994 and primarily owned by the North West Lung Centre charity, the Medicines Evaluation Unit (MEU) is a leading clinical research organisation specialising in pioneering respiratory research and early-phase exploratory trials. Recognised with multiple industry awards, including the Queen’s Award for Enterprise and "Clinical Trial Research Team of the Year," the MEU partners with most major global CROs and pharmaceutical companies. Critically, we also offer a comprehensive, single-site solution for small biotech firms entering clinical trials for the first time. Through our sister company, CRO-Solutions, and our proprietary I.C.A.R.U.S. database of over 43,000 pre-screened volunteers, the MEU ensures immediate trial start-up and expert, hands-on support. This is across all stages of clinical development, delivering efficient, cost-effective solutions for sponsors worldwide.
